期刊文献+

造影剂剂量对冠状动脉介入术后患者肾功能的影响 被引量:1

下载PDF
导出
摘要 目的:探讨不同造影剂剂量对冠状动脉造影患者肾功能的影响。方法:选取广州市增城区人民医院2017年1月至2018年12月150例在行冠状动脉介入术的冠心病患者,按造影剂使用剂量分为大剂量组(≥150 mL)和小剂量组(<150 mL),各75例。观察不同时间两组肾功能的变化,采用Pearson相关系数分析造影剂使用剂量与血清肌酐(Scr)、尿微量白蛋白(mALB)的相关性。结果:术前、术后168 h,两组患者的Scr、mALB比较,差异无统计学意义(P>0.05);术后24 h,大剂量组Scr、mALB高于小剂量组,差异具有统计学意义(P<0.05);造影剂与Scr相关性为r=0.623,P<0.05。造影剂与mALB相关性为r=0.797,P<0.05。结论:造影剂使用剂量与肾功能损害程度呈正相关关系;范围内造影剂使用剂量引起冠脉介入术后患者肾功能损害呈一过性,不会引起永久性造影剂性肾病。
出处 《深圳中西医结合杂志》 2020年第3期184-185,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献7

二级参考文献69

  • 1Yao-Min Hung,Shoa-Lin Lin,Shih-Yuan Hung,Paul Yung-Pou Wang.Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography[J].World Journal of Cardiology,2012,4(5):157-172. 被引量:13
  • 2Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS),European Association for Percutaneous Cardiovascular Interventions (EAPCI),Wijns W. Guidelines on myocardial revascularization[J].European Heart Journal,2010.2501-2555. 被引量:1
  • 3Levine GN,Bates ER,Blankenship JC. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions[J].Circulation,2011.e574-e651. 被引量:1
  • 4Hillis LD,Smith PK,Anderson JL. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery.A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.developed in collaboration with the American Association for Thoracic Surgery,Society of Cardiovascular Anesthesiologists,and Society of Thoracic Surgeons[J].Journal of the American College of Cardiology,2011.e123-e210. 被引量:1
  • 5Nashef SA,Roques F,Michel P. European system for cardiac operative risk evaluation (EuroSCORE)[J].European Journal of Cardio-Thoracic Surgery,1999.9-13. 被引量:1
  • 6Serruys PW,Morice MC,Kappetein AP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J].New England Journal of Medicine,2009.961-972. 被引量:1
  • 7Peterson ED,Dai D,DeLong ER. Contemporary mortality risk prediction for percutaneous coronary intervention:results from 588,398 procedures in the Natio Cardiovascular Data Registry[J].Journal of the American College of Cardiology,2010.1923-1932. 被引量:1
  • 8王玲,倪兆慧,何奔,戴慧莉,刘建平,吴青伟,钱家麒.尿液白介素18在冠状动脉介入术后造影剂肾损伤早期诊断中的意义[J].中华肾脏病杂志,2007,23(12):773-777. 被引量:9
  • 9Feldkamp T,Kribben A.Contrast media induced nephr opathy idefinition,incidence,outcome,pathophysiology,risk factors and prevention [J].Minerva Med,2008,99(2):177-196. 被引量:1
  • 10Susantitaphong P,Cruz DN,Cerda J,et al.World Incidence of AKI:A Meta-Analysis[J].Clin J Am Soc Nephro,2013,8(9):1482-1493. 被引量:1

共引文献189

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部